R Laing

Summary

Country: New Zealand

Publications

  1. pmc 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung
    Amy J Scott-Thomas
    Christchurch School of Medicine and Health Sciences, Department of Pathology, University of Otago, Christchurch, 8140, New Zealand
    BMC Pulm Med 10:56. 2010
  2. ncbi request reprint Community-acquired pneumonia: influence of management practices on length of hospital stay
    R Laing
    Canterbury Respiratory Research Group, New Zealand
    Intern Med J 34:91-7. 2004
  3. ncbi request reprint Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology
    R Laing
    Canterbury Respiratory Research Group, Christchurch School of Medicine and Health Sciences, University of Otago
    N Z Med J 114:488-92. 2001
  4. pmc Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
    W S Lim
    Respiratory Infection Research Group, Respiratory Medicine, Nottingham City Hospital, Nottingham NG5 1PB, UK
    Thorax 58:377-82. 2003
  5. ncbi request reprint Optimizing antibiotic therapy-the Aberdeen experience
    Y Kumarasamy
    Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, UK
    Clin Microbiol Infect 9:406-11. 2003

Collaborators

  • I M Gould
  • Amy J Scott-Thomas
  • W S Lim
  • Y Kumarasamy
  • Stephen T Chambers
  • Michael Epton
  • Mona Syhre
  • John Pearson
  • Philip K Pattemore
  • S A Lewis
  • G I Town
  • T Cadwgan
  • M M van der Eerden
  • I A Gillanders
  • N Karalus
  • J T Macfarlane
  • W G Boersma
  • B Jappy

Detail Information

Publications5

  1. pmc 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung
    Amy J Scott-Thomas
    Christchurch School of Medicine and Health Sciences, Department of Pathology, University of Otago, Christchurch, 8140, New Zealand
    BMC Pulm Med 10:56. 2010
    ..Growth of Ps. aeruginosa releases a "grape-like" odour that has been identified as the microbial volatile organic compound 2-aminoacetophenone (2-AA)...
  2. ncbi request reprint Community-acquired pneumonia: influence of management practices on length of hospital stay
    R Laing
    Canterbury Respiratory Research Group, New Zealand
    Intern Med J 34:91-7. 2004
    ..To identify variation in the management of -community-acquired pneumonia between two New Zealand hospitals and the factors that may account for any differences...
  3. ncbi request reprint Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology
    R Laing
    Canterbury Respiratory Research Group, Christchurch School of Medicine and Health Sciences, University of Otago
    N Z Med J 114:488-92. 2001
    ..Ongoing surveillance of antibiotic resistance and variations in the prevalence of organisms causing community-acquired pneumonia is required to guide clinicians' empiric antibiotic use...
  4. pmc Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
    W S Lim
    Respiratory Infection Research Group, Respiratory Medicine, Nottingham City Hospital, Nottingham NG5 1PB, UK
    Thorax 58:377-82. 2003
    ..A multicentre study was conducted to derive and validate a practical severity assessment model for stratifying adults hospitalised with CAP into different management groups...
  5. ncbi request reprint Optimizing antibiotic therapy-the Aberdeen experience
    Y Kumarasamy
    Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, UK
    Clin Microbiol Infect 9:406-11. 2003
    ....